Hypertension Trial, Recruiting NCT06513975 Sponsor: Sky Labs Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06513975
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are aged 18 years or older but younger than 80 years
  • People who are willing to voluntarily take part and sign a written consent form
  • People who are willing to follow the trial's procedures and schedule

Who may not be able to join:

  • People who do not give their consent to take part in the study
  • People with a Body Mass Index (BMI) of 30 or higher, as the standard blood pressure monitor cuff may not fit the arm correctly
  • People who are pregnant
  • People who have a history of being hospitalised for heart failure, heart valve disease, or a heart attack
  • People who have been diagnosed with an irregular heart rhythm called atrial fibrillation on a heart tracing test (ECG) in the past 6 months
  • People with severe kidney disease who are currently on dialysis
  • People who are unable to perform repeated physical exercises as required by the study
  • People whose upper blood pressure reading (systolic) is higher than 160 mmHg
  • People whose upper blood pressure reading (systolic) is higher than 160 mmHg and/or whose lower blood pressure reading (diastolic) is higher than 100 mmHg, specifically in relation to the exercise testing portion of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Seung Woo Park, Samsung Medical Center

Phone: +82-10-5192-8767

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sky Labs
Registry
ClinicalTrials.gov
Start date
22 November 2024
Est. completion
15 August 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Mean error and standard deviations of differences between CART BP and Reference

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov